Thromb Haemost 1989; 62(04): 1103-1106
DOI: 10.1055/s-0038-1647126
Original Article
Platelets
Schattauer GmbH Stuttgart

Evaluation of the Binding to Fixed Platelets of Agonists and Antagonists of ADP-Induced Aggregation

Ashok K Agarwal
The American Red Cross Cell Biology Laboratory, Rockville, USA
,
Narendra N Tandon
The American Red Cross Cell Biology Laboratory, Rockville, USA
,
Nicholas J Greco
The American Red Cross Cell Biology Laboratory, Rockville, USA
,
Noel J Cusack
*   Department of Pharmacology, King’s College London, London, United Kingdom
,
G A Jamieson
The American Red Cross Cell Biology Laboratory, Rockville, USA
› Author Affiliations
Further Information

Publication History

Received 04 July 1989

Accepted 22 August 1989

Publication Date:
24 July 2018 (online)

Summary

Steady state binding of eleven different ADP analogues to formaldehyde-fixed platelets has been determined in a competitive binding assay using 3H-ADP. The compounds tested were the inactive analogues L-ADP and L-ATP; the agonists 2-chloroadenosine 5’-diphosphate, adenosine 5’-O-(2-thiodiphosphate)and the diastereoisomeric pair Sp-adenosine 5’-(1-thiodiphosphate) (Sp-ADP-α-S) and Rp-adenosine 5’-(1-thiodiphosphate) (Rp-ADP-α-S); and the antagonists adenosine 5’-O-thiomonophosphate, 2-chloroadenosine 5’-O-thiomonophosphate, 2-chloroadenosine 5’-triphoshate, and the diastereoisomeric pair 5’-(1-thiotriphosphate) (Sp-ATP-α-S) and Rp-adenosine 5’-(1-thiotriphosphate) (Rp-ATP-α-S). All compounds tested competed at the high affinity binding sites for ADP previously identified (Blood 1988; 71: 110-6) but in some cases competition could not be demonstrated at the low affinity sites because of the high nucleotide concentrations required. As a group, C2-substituted analogues bound less strongly (Ki >2 μM) than did the analogues without substituents in the purine ring (Ki <0.7 μM). With the pair of diastereoisomeric agonists Sp-ADP-α-S and Rp-ADP-α-S the Ki values at the high affinity site (210 nM and 560 nM) were of the same relative magnitude and in the same direction as their reported potencies as agonists (Ki 4 μM and 20 μM). With the diastereoisomeric antagonists Sp-ATP-α-S and Rp-ATP-α-S a similar relationship was seen between affinity (17 nM and 156 nM) and inhibitory potency (Ki 4 μM and 20 μM). These results may help to differentiate possible mechanisms in the interaction of ADP with its receptors.

 
  • References

  • 1 Born GV R. functional physiology. In: Human Blood Coagulation. Haemostasis and Thrombosis. Briggs R. (Ed) Blackwell; London: 1972. p 159
  • 2 Haslam RJ, Cusack NJ. Blood platelet receptors for ADP and for adenosine. In: Purinergic Receptors. Burnstock G. (Ed) Chapman and Hall; London: 1981. pp 223-285
  • 3 Hawiger J, Sheer ML, Salzman EW. Intracellular regulatory processes in platelets. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsch J, Marder VJ, Salzman EW. (Eds) Lippincott; Philadelphia: 1987. p 710
  • 4 Colman RW, Puri RN, Zhou F. Aggregin: The platelet receptor mediating activation by ADP. In: Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry and Pathology. Jamieson GA. (Ed) Alan R. Liss; New York: 1988. pp 263-277
  • 5 Nachman RL, Ferris B. Binding of adenosine diphosphate by isolated membranes from human platelets. J Biol Chem 1974; 249: 704-710
  • 6 Born GV R, Feinberg H. Binding of adenosine diphosphate by isolated membranes from human platelets. J Physiol 1975; 251: 803-816
  • 7 Legrand C, Caen JB. Binding of 14C-ADP by thrombasthenic platelet membranes. Haemostasis 1976; 5: 231-238
  • 8 Legrand C, Caen JB. Binding of 14C-ADP to normal human and thrombosthenic platelet membranes. Study of the dissociation of the nucleotide from its receptors Haemostasis 1978; 7: 339-351
  • 9 Bennett JS, Colman RF, Colman RW. Identification of adenine nucleotide binding proteins in human platelet membranes by affinity labeling with 5’-fluoro-sulfonylbenzoyl adenosine. J Biol Chem 1978; 253: 7346-7354
  • 10 Bauvois B, Legrand C, Caen JB. Interaction of adenosine and adenine nucleotides with the human platelet membrane. Further characterization of the ADP binding sites Haemostasis 1980; 9: 92-104
  • 11 Lips JP M, Sixma JJ, Schiphorst ME. Binding of adenosine diphosphate to human blood platelets and to isolated platelet membranes. Biochim Biophys Acta 1980; 628: 451-467
  • 12 Macfarlane DE, Mills DC B, Srivastava PC. Binding of 2-azido adenosine [β-32P] diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Biochemistry 1982; 21: 544-549
  • 13 Macfarlane DE, Srivastava PC, Mills DC B. 2-Methylthio-adenosine [β-32P] diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets J Clin Invest 1983; 71: 420-428
  • 14 Jefferson JR, Harmon JT, Jamieson GA. Identification of highaffinity (Kd 0.35 μmol/L) and low-affinity (Kd 7.9 μmol/L) platelet binding sites for ADP analogues. Blood 1988; 71: 110-116
  • 15 Cusack NJ, Hourani SM O. Competitive inhibition by adenosine 5’-triphosphate of the actions of 2’-chloroadenosine 5’-diphosphate, 2-azidoadenosine 5’-diphosphate and 2-methylthioadenosine 5’-diphosphate. Br J Pharmacol 1982; 77: 329-333
  • 16 Cusack NJ, Hourani SM O. Effects of Rp and Sp diastereoisomers of adenosine 5’-0-(1-thiodiphosphate) on human platelets. Br J Pharmacol 1981; 73: 409-412
  • 17 Cusack NJ, Hourani SM O. Adenosine 5’-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br J Pharmacol 1982; 76: 221-227
  • 18 Cusack NJ, Hickman ME, Born GV. Effects of D- and l.renantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido-analogues on human platelets. Proc R Soc Lond 1979; 206: 139-144
  • 19 Hourani SM O, Cusack NJ. Actions and structure-activity relationships of purines on platelets. In: Purines - Pharmacology and Physiological Roles. Stone TW. (Ed). McMillan; London: 1985: 163-173
  • 20 McKeag M, Brown PR. Modification of high-pressure liquid chromatographic nucleotide analysis. J Chromatogr 1978; 152: 253-254
  • 21 Allain JP, Cooper HA, Wagner RH, Brinkhous KM. Platelets fixed with paraformaldehyde: A new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 1975; 85: 318-328
  • 22 Munson PJ, Rodbard D. Ligard. A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107: 220-239
  • 23 Cusack NJ, Hourani SM O. Partial agonist behavior of adenosine 5’-0-(2-thiodiphosphate) on human platelets. Br J Pharmacol 1981; 73: 405-408